Home/Filings/3/0000919574-24-003822
3//SEC Filing

Casdin Amplify Fund, LP 3

Accession 0000919574-24-003822

CIK 0001162194other

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 8:08 PM ET

Size

5.3 KB

Accession

0000919574-24-003822

Insider Transaction Report

Form 3
Period: 2024-06-18
Holdings
  • Common Stock

    (indirect: See footnote)
    545,000
Footnotes (1)
  • [F1]The securities are owned directly by Casdin Amplify Fund, LP ("Amplify") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Amplify ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of Amplify (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP.

Documents

1 file

Issuer

STANDARD BIOTOOLS INC.

CIK 0001162194

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0002028254

Filing Metadata

Form type
3
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 8:08 PM ET
Size
5.3 KB